Company Data

Aprea Therapeutics Inc.

Ticker
APRE
Current Price
$1.83 5.78%
Market Cap
$10.1M
Price Target
Refer to Report
Volume
33.0K
52wk Range
$1.412 - $5.01
Advanced Market Data

Overview

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy